ArticleJournal of Taibah University Medical Sciences2023
Novel biosynthesis of tellurium nanoparticles and investigation of their activity against common pathogenic bacteria.
Article in Journal of Taibah University Medical Sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.
- Microbial mechanisms to transform the super-trace element tellurium: a systematic review and discussion of nanoparticulate phases.World journal of microbiology & biotechnology · 2023Pooled it
- Tellurium Nanoparticles in Biomedicine: Harnessing a "Jekyll and Hyde" Element for Therapy and Diagnosis.Biological trace element research · 2026Review
- Effects of Growth Phases and Intensification of Light on Secondary Metabolites and Agro-Morphological Traits of the St. John's Wort (Plants (Basel, Switzerland) · 2026Article
- Microwave assisted synthesis and bioactive potential of folic acid functionalized tellurium nanoparticles (FA@Te NPs) against HeLa cancer cells.Scientific reports · 2025Article
- Tellurium nanoparticles as antimicrobial agents for multi-drug-resistant infections.RSC advances · 2025Review
- Article
- In vivo evaluation of selenium-tellurium based nanoparticles as a novel treatment for bovine mastitis.Journal of animal science and biotechnology · 2024Article
- Carbon Nanodot-Microbe-Plant Nexus in Agroecosystem and Antimicrobial Applications.Nanomaterials (Basel, Switzerland) · 2024Review
- The Use of Polysaccharide Matrices as a Basis for the Formation of Tellurium Nanoparticles with Different Morphologies.Polymers · 2024Article
- Tellurium and Nano-Tellurium: Medicine or Poison?Nanomaterials (Basel, Switzerland) · 2024Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Tellurium has received substantial attention for its remarkable properties. This study performed Methods: Nine actinomycete isolates were tested for their potential to reduce potassium tellurite (K Results: The most efficient actinomycete isolate was identified as Conclusion: TeNPs combined with vancomycin have successive impact to combat bacteremia for further verification of results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.